Valencia Nutrition Ltd
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
- Market Cap ₹ 76.7 Cr.
- Current Price ₹ 55.0
- High / Low ₹ 65.0 / 23.3
- Stock P/E
- Book Value ₹ 12.4
- Dividend Yield %
- ROCE -56.1 %
- ROE %
- Face Value ₹
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company's working capital requirements have reduced from 210 days to 120 days
Cons
- Stock is trading at 4.43 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -1.15% over past five years.
- Company has high debtors of 264 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.07 | 0.39 | 0.73 | 0.41 | 1.42 | 2.37 | 0.95 | 0.00 | 1.46 | 1.34 | 2.24 | |
0.51 | 1.32 | 1.61 | 2.16 | 1.50 | 3.58 | 6.54 | 3.81 | 0.58 | 2.65 | 2.95 | 4.82 | |
Operating Profit | -0.51 | -1.25 | -1.22 | -1.43 | -1.09 | -2.16 | -4.17 | -2.86 | -0.58 | -1.19 | -1.61 | -2.58 |
OPM % | -1,785.71% | -312.82% | -195.89% | -265.85% | -152.11% | -175.95% | -301.05% | -81.51% | -120.15% | -115.18% | ||
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.00 | -0.49 | 0.00 | 0.00 | 0.31 | 0.64 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.09 | 0.01 | 0.00 | 0.03 | 0.08 |
Depreciation | 0.01 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 | 0.13 | 0.08 | 0.07 | 0.05 | 0.04 |
Profit before tax | -0.52 | -1.29 | -1.26 | -1.46 | -1.16 | -2.14 | -4.33 | -3.57 | -0.67 | -1.26 | -1.38 | -2.06 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
-0.52 | -1.29 | -1.26 | -1.47 | -1.16 | -2.14 | -4.34 | -3.58 | -0.66 | -1.26 | -1.38 | -2.06 | |
EPS in Rs | -129.00 | -126.00 | -29.40 | -19.33 | -30.57 | -3.10 | -2.56 | -0.47 | -0.90 | -0.99 | -1.47 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | 12% |
TTM: | 44% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 16% |
TTM: | -53% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 82% |
1 Year: | 147% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.02 | 0.04 | 0.06 | 0.19 | 0.25 | 0.28 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 | 13.96 |
Reserves | 0.05 | 0.29 | 0.15 | -1.22 | 0.87 | 0.38 | -0.75 | -4.33 | -4.99 | -6.25 | -7.64 | 3.37 |
0.08 | 0.08 | 0.08 | 0.99 | 0.18 | 0.18 | 0.65 | 0.56 | 0.60 | 2.18 | 5.34 | 1.43 | |
0.08 | 0.10 | 0.23 | 0.37 | 0.32 | 0.57 | 1.32 | 1.86 | 1.24 | 1.26 | 2.71 | 0.40 | |
Total Liabilities | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 19.16 |
0.04 | 0.06 | 0.08 | 0.09 | 0.09 | 0.11 | 1.44 | 1.41 | 0.22 | 0.15 | 2.32 | 2.35 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.48 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.58 |
0.19 | 0.45 | 0.44 | 0.24 | 1.53 | 1.30 | 5.34 | 2.27 | 2.22 | 2.63 | 3.68 | 5.75 | |
Total Assets | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 19.16 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | -1.23 | -1.12 | -1.28 | -2.56 | -4.10 | -2.49 | -1.35 | -1.55 | -0.76 | |
0.00 | 0.00 | -0.06 | -0.05 | -0.05 | -0.01 | -2.05 | -0.09 | 1.12 | 0.00 | -2.22 | |
0.00 | 0.00 | 1.14 | 1.15 | 2.47 | 1.68 | 8.89 | -0.17 | 0.42 | 1.58 | 3.13 | |
Net Cash Flow | 0.00 | 0.00 | -0.15 | -0.03 | 1.14 | -0.89 | 2.73 | -2.76 | 0.20 | 0.03 | 0.15 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 208.57 | 149.74 | 40.00 | 17.80 | 33.42 | 3.08 | 7.68 | 72.50 | 264.22 | ||
Inventory Days | 851.67 | 214.71 | 62.93 | 124.43 | 112.54 | 114.68 | 16.50 | 2,920.00 | 200.39 | 143.54 | |
Days Payable | 182.50 | 118.09 | 132.16 | 82.95 | 63.87 | 48.09 | 115.48 | 8,030.00 | 76.34 | 49.21 | |
Cash Conversion Cycle | 877.74 | 246.36 | -29.22 | 59.28 | 82.08 | 69.67 | -91.30 | 196.55 | 358.54 | ||
Working Capital Days | 782.14 | 149.74 | -70.00 | 53.41 | 102.82 | 44.66 | 30.74 | 300.00 | 119.85 | ||
ROCE % | -460.71% | -360.00% | -1,168.00% | -180.95% | -200.00% | -135.55% | -81.26% | -43.71% | -92.65% | -56.13% |
Documents
Announcements
-
Non-Applicability Of Disclosures Of Related Party Transactions By Valencia Nutrition Limited
13 Nov - Non-applicability of related party transaction disclosures.
-
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015
13 Nov - Statement of deviation for Rights Issue funds.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. Wednesday, November 13, 2024, At 1:00 P.M And Concluded At 05.30 P.M.
13 Nov - Approval of standalone unaudited financial results for H1 2024.
- Standalone Unaudited Financial Statements For The Half-Year Ended September 30, 2024, Of Valencia Nutrition Limited 13 Nov
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, November 13, 2024
25 Oct - Board meeting scheduled for November 13, 2024.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases